Wednesday 4 September 2024

Potential of molecular profiling to refine surgical and radiotherapy decision-making in patients with meningioma

 Findings from the RTOG-0539 study, the largest meningioma cohort with multiplatform molecular ever conducted, was recently published in Nature Medicine.  Using retrospective data on 2,824 meningiomas, researchers found that "gross tumour resection was associated with longer progression-free survival across all molecular groups and longer overall survival in proliferative meningiomas." 

Click here to learn more about this study. 

Source mentioned: 

Wang JZ, Patil V, Landry AP, et al. Molecular classification to refine surgical and radiotherapeutic decision-making in meningiomaNature Medicine; Published online 21 August 2024. DOI: https://doi.org/10.1038/s41591-024-03167-4

No comments:

Post a Comment